跳至主要内容
临床试验/ISRCTN89207035
ISRCTN89207035已完成未知

A placebo-controlled trial to evaluate two locally delivered antibiotic-containing (piperacillin and tazobactam verus doxycycline) gels in stage III-IV periodontitis patients

MegaGen Dental Implant Romania0 个研究点目标入组 100 人开始时间: 2022年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36837504/ (added 20/04/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. All subjects were diagnosed with periodontitis stage III and IV
  • 2. All participants fulfilled the following inclusion criteria:
  • 2.1. Aged between 25 and 80 years old
  • 2.2. At least 8 sites with PD = 5 mm and showing bleeding on probing
  • 2.3. Clinical attachment loss =3 mm
  • 2.4. Patients who have not undergone periodontal therapy in the last 12 months

排除标准

  • Patients with the following conditions were excluded:
  • 1. Clinically relevant psychiatric disorders
  • 2. Alcohol consumption
  • 3. Autoimmune disorders
  • 4. HIV infection
  • 5. Untreated diabetes mellitus
  • 6. Pregnancy or breastfeeding
  • 7. Patients who have received periodontal therapy in the last 12 months
  • 8. Patients who reported local and/or systemic antibiotic therapy within the 3 months before the baseline examination of the study
  • 9. Candidiasis
  • 10. Allergies to piperacillin, tazobactam, doxycycline, or to any tetracycline or penicillin or to any excipient of the products used
  • 11. Systemic medication that can influence the clinical features of periodontitis
  • 12. Patients who have rinsed or irrigated with antiseptics less than a month before the initial examination
  • 12. Conditions that require antibiotic protection

研究者

发起方
MegaGen Dental Implant Romania

相似试验

Comparison of two adjunctive locally delivered... | 临床试验